Table 1 Histology, degree of differentiation and TNM stage at the time of diagnosis of the primary tumor.
From: Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
Histology | Number of patients (n:60) | Percentage |
|---|---|---|
Serous cystadenocarcinoma | 38 | 63,3% |
Mucinous adenocarcinoma | 8 | 13,4% |
Mixed | 4 | 6,7% |
Clear cell | 3 | 5% |
Endometrioid | 2 | 3,4% |
Unknown | 5 | 8,4% |
Degree of differentiation | ||
G1 | 16 | 26,7% |
G2 | 18 | 30% |
G3 | 26 | 43,3% |
TNM stage | ||
I | 8 | 13,3% |
II | 18 | 30% |
III | 22 | 36,7% |
IV | 12 | 20% |